The only PMV vaccine not to contain mineral oil
This makes it safer in use and if accidentally self injected. Supplied with needles, syringe, record card etc. Patented formula Please note:- immunity builds up over a period of time.
Presentation
Colombovac PMV is an inactivated adjuvanted vaccine based on an avian paramyxovirus serotype 1 (PMV-1) vaccine strain.
Uses
For the primary and booster vaccination of healthy, susceptible, immune competent pigeons against paramyxovirus infections caused by the PMV-1 serotype.
Dosage and administration
Shake the vial before use. 0.2 ml by subcutaneous injection. Administer into the neck in the direction of the back.
Dosage regimen
1. Racing pigeons – All birds in the loft should be given one vaccination annually not less than 14 days before the beginning of the racing season.
Young birds may be vaccinated with Colombovac PMV from 3 weeks of age when a single injection will provide immunity for 1 year. Following vaccination avoid contact with birds from other lofts for at least 14 days.
All late-hatched young pigeons should be given one vaccination from 3 weeks of age and not mixed with birds from other lofts for at least 14 days.
All adult birds in the loft should be given a single booster vaccination annually. Where the annual booster vaccination may interfere with the training or racing programme, it may be brought forward prior to the commencement of each racing season.
2. Show pigeons – All birds on the premises should be given one vaccination annually not less than 14 days before the beginning of the show season.
Young birds may be vaccinated with Colombovac PMV from 3 weeks of age when a single injection will provide immunity for 1 year. Following vaccination avoid contact with birds from other sources for at least 14 days.
All adult birds on the premises should be given a single booster vaccination annually
Contra-indications, warnings, etc
FOR ANIMAL TREATMENT ONLY
Shake the vial before use. Use entire contents when first opened. Dispose of used container by incineration.
In cases of adverse reaction treat immediately with glucocorticoid intravenously or adrenaline intramuscularly.
Only healthy birds should be vaccinated.
Administer the vaccine only by the subcutaneous route. Aseptic precautions should be observed at all times.
Withdrawal period zero days.
Pharmaceutical precautions
Store at +2°C to +8°C. Do not freeze. Protect from light.
Keep out of the reach of children
Legal category
NFA-VPS (previously P).
Packaging Quantities
Vial of 10 ml (50 doses)
Vial of 20 ml (100 doses)
Further information
The incubation period for pigeon paramyxovirosis may be a few days to several weeks. However, after infection with the wild virus, pigeons excrete the virus from the eye and in the droppings within 3-4 days. This means that infected birds can be a danger to others some days before their own symptoms appear. Excretion of wild virus from the infected bird continues for up to 6 weeks. This information is important since, in addition to direct bird to bird contact at competitions and shows, the disease can be spread by indirect means such as hands, overalls, caps, boots and contaminated objects such as baskets and trucks.
An owner should forbid visits to the loft by anyone in contact with unvaccinated pigeons and new birds (either purchased or lent for mating) should not be brought in unless vaccinated at least 14 days previously.
In any animal population there will be a small number of individuals which fail to respond fully to vaccination. Successful vaccination depends upon correct storage and administration of vaccine and the animal's ability to respond. Immune competence can be influenced by genetic factors, intercurrent infection, age, nutritional status, concurrent drug therapy, stress, etc.
Maternally-derived antibody (MDA) can interfere with the development of active immunity. Where it is likely that recent field infection or vaccination of the parent flock
has stimulated a high antibody titre and consequently a high level of MDA, the timing of the vaccination programme should be planned accordingly.
Product licence number
Vm 01596/4162 | 
